Abstract
Steven L. Kanter Photo courtesy of UMKC School of Medicine
Steven L. Kanter, MD, neurosurgeon and leader in the field of medical informatics, has been appointed dean of the School of Medicine at the University of Missouri-Kansas City (UMKC). Dr. Kanter joins UMKC from the University of Pittsburgh School of Medicine in Pennsylvania, where has been a faculty member since 1991 and Vice Dean since 2002. In his new post, he also serves as a professor in the Department of Biomedical and Health Informatics and Professor of Medicine in the Department of Internal Medicine, and will hold the Merl and Muriel Hicklin Foundation Endowed Chair at the School of Medicine. Dr. Kanter's tenure at UMKC began Oct. 1. He succeeds Betty Drees, MD, who led the UMKC School of Medicine for 12 years. Dr. Drees remains on the UMKC faculty.
Dr. Kanter earned his MD at the University of Texas Medical School in San Antonio. He completed residency at the University of Florida and served on the faculty at Texas A&M University College of Medicine before moving to the University of Pittsburgh. He is a member of the American Medical Informatics Association, the World Association of Medical Editors and the Association for Medical Education in Europe (AMEE). He is former Editor-in-Chief of Academic Medicine, the Journal of the Association of American Medical Colleges (AAMC), and a former Fellow in Medical Informatics for the National Library of Medicine. He was the 2013 recipient of the Merrell Flair Award, given by the AAMC's Group on Educational Affairs. In 2007, he received the AMEE's Patil Award for Best Medical Education Research Presentation.
University of Michigan Frankel CVC Names Director
Thomas Wakefield Photo courtesy of University of Michigan Health System
Thomas Wakefield, MD, has been named as a director of the University of Michigan (U-M) Frankel Cardiovascular Center (CVC). His four-year appointment was effective on July 1. He succeeds James C. Stanley, MD, who will resume his post as professor of vascular surgery and associate chair of the U-M Department of Surgery. Dr. Wakefield joins directors Kim A. Eagle, MD, David J. Pinsky, MD, and Richard L. Prager, MD, and chief administrative officer Linda R. Larin, MBA, on the CVC leadership team.
Dr. Wakefield earned his MD from the Medical College of Ohio in 1978. He completed general surgery residency at the U-M and a vascular surgery fellowship at the U-M Health System. He has served at the U-M for 36 years, during which he has held a number of leadership posts. From 2002–2012, he was the S. Martin Lindenauer Collegiate Professor of Vascular Surgery and, in 2012, was named the James C. Stanley Professor of Vascular Surgery, a professorship created to honor the career of his predecessor. He has served as head of vascular surgery at the U-M since 2004.
Dr. Wakefield's laboratory has focused on studying the relationship of inflammation to thrombosis and thrombus amplification as well as examining the role of plasminigine activator inhibitor-1 (PAI-1) in venous thrombosis. He is past-president of the American Venous Forum, Michigan Vascular Society, and the Frederick A. Coller Surgical Society.
Interim Dean Named at Geisel School of Medicine at Dartmouth
Duane Compton Photo courtesy of Geisel School of Medicine at Dartmouth
Duane Compton, PhD, has been named interim dean at the Geisel School of Medicine at Dartmouth College. Dr. Compton, professor of biochemistry and senior associate dean for research, began his interim appointment on July 15. He succeeds Wiley “Chip” Souba, who served as Geisel dean for four years. Dr. Souba chose not to seek reappointment to a second term as dean but remains on the faculty of the medical school.
Dr. Compton received his PhD from the University of Texas Health Science Center at Houston in 1988 and completed his postdoctoral training in the field of cell biology at the Johns Hopkins University School of Medicine. He joined the faculty at Dartmouth in 1993. His lab is focused on understanding the mechanisms of chromosome segregation during cell division in human cells. He received a “Method to Extend Research in Time” (MERIT) Award in 2013 from the National Institutes of Health to support this work.
Director Named for New Center for Medical Devices at Mount Sinai Heart
Julie Swain Photo courtesy of Mount Sinai
Julie Swain, MD, will serve as director for the newly established Center for Medical Devices (CMeD) at Mount Sinai Heart at Icahn School of Medicine at Mount Sinai. She will also serve as Professor of Cardiovascular Surgery and Director of Clinical Research in the Department of Cardiovascular Surgery at Mount Sinai. Dr. Swain is a leading cardiothoracic surgeon and clinical trials expert and has consulted for the U.S. Food and Drug Administration's (FDA's) Division of Cardiovascular Devices for two decades.
The new Center was established with the aim of advancing the field of cardiovascular medicine and expeditiously facilitating the delivery of novel medical devices to cardiac patients. Services provided through CMeD include cardiac medical device assessment and evaluation, regulatory approval strategies, advanced clinical trial design, data interpretation, assistance with FDA submissions, and potential access to clinical testing at Mount Sinai.
Interim Dean of the School of Medicine and Acting Senior VP of Health Affairs Named at Meharry
Marquetta Faulkner, MD, MBA, has been appointed as interim dean of the School of Medicine and acting senior vice president of Health Affairs at Meharry Medical College. Dr. Faulkner has served at Meharry since 1989, when she joined the faculty as an assistant professor in the Department of Internal Medicine. During her tenure at Meharry, she has held a number of leadership posts, including chief of nephrology, medical director of the Meharry-DCI Chronic Hemodialysis Unit, and medical director for the Meharry Medical Group. She has also served as associate dean of Graduate Medical Education, vice-chair of the Department of Internal Medicine and assistant chief of service at Nashville General Hospital. In her interim role, she succeeds Charles P. Mouton, MD.
Dr. Faulkner earned her MD from Meharry in 1981 and completed residency at Hubbard Hospital (now known as Nashville General Hospital). She will serve as interim until a new dean and senior vice president of health affairs is hired.
Sixth President of Morehouse School of Medicine Assumes Post
Valerie Montgomery Rice, MD, began service as the sixth president of Morehouse School of Medicine (MSM) on July 1. She is the first woman to lead the free-standing medical school. She will continue to serve as the school's dean, a post she has held along with that of executive vice president of MSM, since 2001. The inauguration ceremony was held September 11–13 in Atlanta, GA.
Dr. Montgomery Rice earned her MD from Harvard Medical School. She completed residency in obstetrics and gynecology at Emory University School of Medicine and a fellowship in reproductive endocrinology and infertility at Hutzel Hospital in Detroit, MI. She also completed the Executive Leadership in Academic Medicine program at Drexel University College of Medicine. In a research partnership with the University of Zambia, she is focusing on the development of a vaginal microbicide for the prevention of HIV.
Prior to joining Morehouse, Dr. Montgomery Rice served as dean of the School of Medicine and senior vice president of health affairs at Meharry Medical College in Nashville, TN. She was also the founder and former director of the Center for Women's Health Research at Meharry. Before her tenure at Meharry, Dr. Montgomery served in a number of leadership posts at the University of Kansas School of Medicine.
Executive Director Appointed at USC Institute of Urology at Keck Medicine of USC-Beverly Hills
Gerhard Fuchs Photo Credit: Van Urfalian/©Keck Medicine of USC
Gerhard Fuchs, MD, FACS, professor of clinical urology at the Keck School of Medicine of the University of Southern California (USC), has been appointed as executive director of the USC Institute of Urology at Keck Medicine of USC - Beverly Hills. He will also serve the Institute as director of the Men's Health Center, director of education and director of quality assurance/improvement. His appointment was effective on July 15.
Dr. Fuchs is known for his pioneering use of extracorporeal shockwave lithotripsy (ESWL), a minimally invasive treatment for eliminating kidney stones, and is a leader in advanced endoscopic and urologic laparoscopic surgery. He previously served at Cedars-Sinai Medical Center since 2000, where he was director of the Minimally Invasive Urology program, vice chairman of the Department of Surgery and director for the Urology Residency and Fellowship programs. He was also a clinical professor of Urology at the David Geffen School of Medicine at the University of California Los Angeles (UCLA).
Dr. Fuchs earned his undergraduate degree and MD from the University of Heidelberg in Germany. He also holds a doctoral degree from the University of Freiburg Medical School, Germany, which is the equivalent of a PhD in Europe. He is board certified by the American and German Boards of Urology, and is a Fellow of the American College of Surgeons.
Regional Dean of Mercer University School of Medicine Columbus Campus Appointed
Alice House Photo courtesy of Mercer University
Alice House, MD, FAAFP, has been appointed regional dean of the Columbus campus of Mercer University School of Medicine. Dr. House has served on the faculty of the Mercer School of Medicine since 2002, when she joined as family medicine clerkship director. She has also served as professionalism program director, director of student advising, and, most recently, senior associate dean for student affairs and admissions. Her new appointment was effective July 1.
Dr. House is a 1995 alumna of the Mercer University School of Medicine. She completed family medicine residency training at The Medical Center of Central Georgia and was in private practice prior to joining the Mercer faculty.
Director of Lung Cancer Screening Program at Temple University Hospital Named
Cherie P. Erkmen Photo courtesy of Temple University School of Medicine
Cherie P. Erkmen, MD, has been appointed Director of the Lung Cancer Screening Program at Temple University Hospital. She will also serve as Associate Professor of Surgery at Temple University School of Medicine. Her appointment was effective July 21, 2014.
Prior to joining Temple, Dr. Erkmen was Assistant Professor of Surgery and Medicine at the Geisel School of Medicine at Dartmouth and Chief of the Thoracic Oncology Program at Dartmouth's Norris Cotton Cancer Center in Lebanon, NH. Her research has focused on lung cancer, esophageal cancer, thymoma, thymic carcinomas, chest wall tumors and rib fixation, as well as intraoperative imagining techniques and modeling of esophagectomy. She is a leader in the practice of shared decision-making for lung cancer screening. During her tenure at Dartmouth, she initiated a cancer screening program focused on the shared decision-making process between patients and their physicians.
Dr. Erkmen earned her MD from the University of California, Los Angeles Medical School. She completed a General Surgery Residency and Thoracic Surgery Fellowship at Brigham & Women's Hospital in Boston. She is board-certified in General Surgery and Thoracic Surgery. Her work is supported with funding from the National Institutes of Health, and she has been recognized with numerous honors and awards, including the Norris Cancer Center Award for Excellence, the Dartmouth Institute $25,000 Prize for Clinical Program Development and the Society of Surgical Oncology Award for Basic Science Presentation. She is a member of the American College of Surgeons, the American Association of Chest Physicians, the Society of Thoracic Surgery and the American Society of Clinical Oncology. Dr. Erkmen completed an American Association of Thoracic Surgery Traveling Fellowship in Chiba, Japan.
Chair for Department of Preventive Medicine Named at UTHSC College of Medicine
Teresa Waters Photo courtesy of the University of Tennessee Health Center
Teresa Waters, PhD, has been appointed as the new chair for the Department of Preventive Medicine in the University of Tennessee Health Science Center (UTHSC) College of Medicine. Dr. Waters has served on the UTHSC faculty in the Department of Preventative Medicine since 2000. Her new appointment began on August 1. She succeeds Karen Johnson, MD, MPH, who served as interim chair for the department for more than four years.
Dr. Waters earned her PhD in economics from Vanderbilt University in 1992. Prior to joining UTHSC, she was on the faculty of Northwestern University. During her tenure at Northwestern, she served as assistant director and interim deputy director of the Institute for Health Services Research and Policy Studies.
Dr. Waters is on the editorial board of the journal, Medical Care Research and Review, and has served as a member and ad hoc reviewer on a number of National Institutes of Health (NIH) and Agency for Healthcare Research and Quality (AHRQ) Study Sections. Her research is funded by AHRQ, the Centers for Medicare and Medicaid Services and the NIH's National Institute on Aging. Among other distinctions she has received for outstanding teaching, she was honored with a University of Tennessee Student Government Association Excellence in Teaching Award in 2003.
Chief of the Division of Pediatric Infectious Diseases Named at the Children's Hospital at Montefiore and Albert Einstein College of Medicine
Betsy Herold Photo courtesy of Albert Einstein College of Medicine
Betsy Herold, MD, has been named as Chief of the Division of Pediatric Infectious Diseases at The Children's Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine. She also serves as vice chair for research development in the Department of Pediatrics at CHAM and Einstein and is a professor of Pediatrics, Microbiology and Immunology, and Obstetrics & Gynecology and Women's Health and holds the Harold and Muriel Block Chair of Pediatrics at Einstein. She assumed her new post on July 1.
Dr. Herold is widely known for her innovative and ground breaking translational research in the prevention of viral infections, and she has directed and led development of the Translational Prevention Research Center at Einstein. She has served at Montefiore and Einstein since 2007, prior to which she was the division chief of Pediatric Infectious Diseases at the former Mount Sinai School of Medicine (now the Icahn School of Medicine at Mount Sinai).
Dr. Herold earned her MD from the University of Pennsylvania Medical School in 1982 and completed residency, fellowship and postdoctoral virology training at Northwestern University.
She is a board-certified pediatric infectious disease specialist. Her laboratory has focused on developing a vaccine for herpes simplex viruses (HSV) and also directs clinical trials aimed at defining effective strategies to protect women and babies from HSV and HIV. Her work is supported with funding from the National Institutes of Health.
Dr. Herold has received numerous honors for her work, including: the Henry and Jacob Lowenberg Prize in Pediatrics from the University of Pennsylvania (1982); the Pediatric Infectious Disease Society Young Investigator Award (1995); the IDSA/Burroughs Welcome Young Investigator Award in Virology (1995); the University of Chicago Department of Pediatrics’ Outstanding Teacher Award (1996); and the Albert Einstein College of Medicine Faculty Mentoring Award (2012). She is secretary-treasurer of the Pediatric Infectious Disease Society and a fellow of the Infectious Disease Society of America.
Associate Director of Globalization and Cancer Named at UAB Comprehensive Cancer Center
Isabel Scarinci Photo credit: Steven Wood Courtesy of the University of Alabama at Birmingham
Isabel Scarinci, MPH, PhD, associate professor in the University of Alabama at Birmingham (UAB) Division of Preventive Medicine, has been named to the newly created position of associate director for globalization and cancer at the UAB Comprehensive Cancer Center. Dr. Scarinci is an associate scientist at the UAB Minority Health and Research Center, Comprehensive Cancer Center, John J. Sparkman Center for International Public Health Education, Center for Outcomes and Effectiveness Research and Education, and the Center for Health Promotion.
Dr. Scarinci is an experienced international researcher and currently has two funded projects in Brazil. Her research is aimed at understanding psychological and sociocultural factors that influence the preventative care behaviors of women and minorities. In particular, she has focused on cancer prevention among low-income, minority Latinas and African-Americans, and immigrant women; socioeconomic status and health outcomes; and depression. She was recently appointed as honorary consul for Brazil and confirmed by the U.S. Department of State.
Dr. Scarinci earned her MPH from the UAB in 1993. She earned an MS in Psychology in 1996 from Louisiana State University (LSU) in Baton Rouge and completed a pre-doctoral internship at Massachusetts General Hospital in Boston prior to earning her PhD in Clinical Psychology in 1998 from LSU.
Head of Radiology Named at Washington University School of Medicine
Richard L. Wahl Photo courtesy of Washington University School of Medicine
Richard L. Wahl, MD, has been named the Elizabeth E. Mallinckrodt Professor and head of radiology at Washington University School of Medicine in St. Louis. He will also serve as director of the Mallinckrodt Institute of Radiology. He succeeds R. Gilbert Jost, MD, who directed the Institute for 15 years.
Dr. Wahl joins Washington University in St. Louis (WUSTL) from Johns Hopkins University, where he was the Henry N. Wagner Jr., MD, Professor and director of the Division of Nuclear Medicine. He also served as vice chair for technology and new business development in the Russell H. Morgan Department of Radiology and Radiological Sciences and was a professor of oncology. Dr. Wahl's work has focused on developing targeted radiopharmaceuticals to diagnose and treat cancer, and he was among the first to use radioimmunotherapy to treat non-Hodgkin's lymphoma. He is also a leader in the diagnostic use of positron emission tomography.
Dr. Wahl earned his MD and completed residency at Washington University School of Medicine. He completed internship at the University of California at San Diego School of Medicine before returning to Washington University for training in diagnostic radiology and nuclear medicine. He accepted his first faculty appointment at the University of Michigan in 1983.
Dr. Wahl has received numerous honors and awards for his work, including: U.S. Department of Energy Achievement Award; the Tetalman, Berson and Yalow and two Alavi-Mandel awards from the Society for Nuclear Medicine and Molecular Imaging; and the Academy of Molecular Imaging's Distinguished Scientist Award. He is a fellow in the American College of Radiology.
Associate Dean for Global Health, Vaccinology and Infectious Diseases Named at University of Maryland School of Medicine
Myron M. Levine, MD, DTPH, has been named as Associate Dean for Global Health, Vaccinology and Infectious Diseases at the University of Maryland School of Medicine (SOM). Dr. Levine will transition from his current role as Director of the Center for Vaccine Development to his new post in January 2015. He is the co-founder of the Center for Vaccine Development, which he has directed for 40 years.
Dr. Levine earned his MD from the Medical College of Virginia in 1967 and DTPH from the London School of Hygiene & Tropical Medicine in 1974. He is board certified in both Pediatrics and Preventive Medicine. A pioneer in the discipline of vaccinology, Dr. Levine's training programs were among the first in the field to receive funding from the National Institutes of Health.
At the University of Maryland SOM, Dr. Levine is the Bessie & Simon Grollman Distinguished Professor in the Department of Medicine, and has secondary appointments in Epidemiology & Public Health, Microbiology & Immunology, and Pediatrics. He also serves as a consultant for many organizations, including the World Health Organization, the National Institutes of Health (NIH), the NIH Vaccine Research Center, the Institute of Medicine, the U.S. Department of Defense, and multiple vaccine biotech companies and vaccine manufacturers.
Dr. Levine is a member of the Institute of Medicine of the National Academy of Sciences, the Association of American Physicians, the American Society of Clinical Investigation; and the Academy of Microbiology. He is Past President of both the American Epidemiological Society and the American Society of Tropical Medicine and Hygiene (ASTMH). He was a member of the initial Working Group of the Global Alliance for Vaccines and Immunization (GAVI Alliance) and was Co-Chair of the GAVI Task Force on Research and Development. He has received numerous honors and awards for his work, including the Albert B. Sabin Gold Medal Award for lifetime achievement in vaccinology, the Maurice Hilleman/Merck Award from the American Society for Microbiology, and the Donald Mackay Medal of the ASTMH for lifetime contributions in improving tropical public health. The President of Mali awarded him the rank of “Grand Officer of the National Order of Mali” for introducing new pediatric vaccines to the country. Dr. Levine is Senior Editor of the 4th edition of the textbook, New Generation Vaccines.